Background
==========

Understanding how elite controllers (EC), patients controlling virus without antiretroviral therapy (ART), differ from those with chronic disease is an area of intense investigation. HIV Gag specific (sp) cytotoxic T lymphocytes (CTL) play a dominant role in this control. Unfortunately, most HIV sp CTL are primed for apoptosis. We hypothesize that EC up-regulate survival factors allowing them to resist apoptosis.

Methods
=======

We examined pro- and anti-apoptotic factors in HIV Gag specific CTL in EC (viral load (VL) \< 50 off ART), successfully treated (ST) (VL \< 50 on ART), and untreated viremics (V). Using flow cytometry based assays, we performed cross-sectional and longitudinal analysis of pro-apoptotic (cleaved caspase-3) vs. anti-apoptotic (Bcl-2) markers in HIV specific CD8 T cells examining spontaneous cell death.

Results
=======

VL only partially drives expression of cleaved caspase-3 (CC3). CC3^hi^HIV sp CTL in EC were not only lower compared to V (2.3 vs. 13%, respectively) but also lower than ST (5.4%) (p \< 0.05). Bcl-2 trended towards higher levels in HIV sp CTL of EC and ST compared to V. Combining these makers we found differences in CC3^hi^/Bcl-2^lo^HIV sp CTL with the greatest number of HIV sp CTL at risk of apoptosis in viremics (6.5%), followed by ST (2.1%) and EC (0.80%) (p \< 0.05). In a longitudinal analysis pre and post ART we found decreases in both CC3^hi^HIV sp CTL and CC3^hi^/Bcl-2^lo^CTL after successful treatment. CC3^hi^/Bcl-2^lo^populations represent cells at greatest risk of undergoing apoptosis and this phenotype appears to be only partially reversible with ART.

Conclusion
==========

EC have a survival advantage over patients with chronic disease even when treated with ART. Elucidating pro- and anti-apoptotic factors contributing to the survival of CTL in EC including costimulatory signaling necessary to generate these CTL capable of resisting apoptosis is paramount to development of effective HIV-1 vaccines.
